Leaflet IMOGAM RABIES 150UI / ml solution for injection
Indicated for: immunosuppression
Route of administration: injectable
Substance: human anti-rabies immunoglobulin (immunoglobulin)
ATC: J06BB05 (Antiinfectives for systemic use | Immunoglobulins | Specific immunoglobulins)
Risk of severe allergic reaction. Seek urgent medical help if serious symptoms occur.
This medicine is subject to additional monitoring.
Human rabies immunoglobulin is a plasma-derived product used to prevent rabies in individuals exposed to the rabies virus, usually through bites from infected animals. It provides passive immunity by supplying specific antibodies against the rabies virus.
The medication is administered via intramuscular injection, as directed by a doctor, and is used in combination with the rabies vaccine.
Side effects may include pain at the injection site, fever, allergic reactions, or, in rare cases, anaphylactic reactions.
Patients should inform their doctor about any known allergies or other medications they are taking. Pregnant or breastfeeding women should consult a specialist before use.
General data about IMOGAM RABIES 150UI / ml
- Substance: human anti-rabies immunoglobulin
- Date of latest medicines list: 01-03-2017
- Product code: W63206001
- Concentration: 150UI / ml
- Pharmaceutical form: solution for injection
- Quantity: 1
- Product type: Generic medicine
- Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.